Runben Biotechnology Co., Ltd. (SHA:603193)
23.46
+0.14 (0.60%)
Feb 27, 2026, 3:00 PM CST
-17.60% (1Y)
| Market Cap | 9.44B -9.0% |
| Revenue (ttm) | 1.52B +21.8% |
| Net Income | 305.33M -0.3% |
| EPS | 0.76 -0.1% |
| Shares Out | 404.59M |
| PE Ratio | 30.72 |
| Forward PE | 27.98 |
| Dividend | 0.46 (1.95%) |
| Ex-Dividend Date | Sep 18, 2025 |
| Volume | 865,042 |
| Average Volume | 2,293,868 |
| Open | 23.32 |
| Previous Close | 23.32 |
| Day's Range | 23.32 - 23.46 |
| 52-Week Range | 23.20 - 44.00 |
| Beta | 0.05 |
| RSI | 40.83 |
| Earnings Date | Apr 23, 2026 |